Ray Therapeutics

San Diego, United States

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

Apr 2026

Series B

Biotechnology Health Care Therapeutics

Top Investors

NorwestJanus Henderson InvestorsNovo HoldingsAdage Capital ManagementDeerfield Management

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ray Therapeutics

Who are Ray Therapeutics's investors?

Ray Therapeutics's investors include Norwest, Janus Henderson Investors, Novo Holdings, Adage Capital Management, Deerfield Management.

Where is Ray Therapeutics headquartered?

Ray Therapeutics is headquartered in San Diego, United States.

What does Ray Therapeutics do?

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

What stage is Ray Therapeutics at?

Ray Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 21, 2026.

MLA

"Ray Therapeutics — Funding & Investors." VCBacked, April 21, 2026, https://www.vcbacked.co/company/ray-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Ray Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/ray-therapeutics

Wikipedia (cite web)

{{cite web |title=Ray Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ray-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 21, 2026.

Similar Companies in Biotechnology